- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02002845
A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Effectiveness Endpoint:
• Ability to complete procedure without a need for conversion to a non-robotic approach
Safety Endpoint:
Assessment of adverse events through post-operative follow-up including but not limited to:
• Bleeding
▪ Mortality
Additional endpoints evaluated may include:
- Procedure times
- Length of hospital stay
- Volume of tissue resected
- Use of tissue sealants
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Connecticut
-
Middletown, Connecticut, United States, 06457
- Middlesex Hospital
-
-
Michigan
-
Ypsilanti, Michigan, United States, 48197
- St. Jose Mercey Health System
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The specific surgical procedure involved a lingual tonsillectomy, tongue base resection, or a partial glossectomy procedure.
- Subject was ≥18 years of age at the time of procedure
Exclusion Criteria:
- Subject underwent a benign non-tumor TORS procedure that did not involve either a lingual tonsillectomy, tongue base resection or partial glossectomy.
- Subject underwent a TORS procedure for oropharyngeal cancer
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Robotic arm
Patient who have undergone benign non-tumor TORS procedures using the da Vinci Surgical System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Effectiveness Endpoint
Time Frame: intra-operative
|
Ability to complete procedure without a need for conversion to a non-robotic approach
|
intra-operative
|
|
Primary Safety endpoint
Time Frame: up to 30 days after surgery
|
Assessment of adverse events through post-operative follow-up including but not limited to: • Bleeding ▪ Mortality |
up to 30 days after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Shilpa Mehendale, MS, Intutive Surgical
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Non-Tumor based TORS procedure
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on robotic surgery using the da Vinci Surgical System
-
National Cancer Center, KoreaUnknown
-
Mayo ClinicCompletedHead and Neck Cancer | Oropharyngeal NeoplasmsUnited States
-
Wake Forest University Health SciencesCompletedHead and Neck NeoplasmsUnited States
-
University of PennsylvaniaCompleted
-
Intuitive SurgicalCompleted
-
Stanford UniversityTerminatedHypopharyngeal Neoplasms | Laryngeal Neoplasms | Head and Neck CancersUnited States
-
Intuitive SurgicalRecruiting
-
Intuitive SurgicalCompleted
-
Stanford UniversityRecruitingEndometriosis | Hysterectomy | Cholecystectomy | Sleeve Gastrectomy | Splenectomy | Thymectomy | Ureteral Re-implant | Cervical and Thoracic Tracheoplasty | Lung Segmentectomy | Bronchoplasty | Endoscopic Laryngeal/Pharyngeal Suturing | Vocal Feminization | Laryngeal Cleft Repair | Endolaryngeal Adjacent Tissue Transfer and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompletedCancer | Complications | Surgical Procedure, Unspecified | Other Reconstructive Surgery | Failure of Muscle GraftUnited States